Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 06/18/2013

Company Name Symbol %Change
STAAR SURGIC STAA
10.98%
DTS INC DTSI
6.89%
ANIKA THERAP ANIK
6.04%
LUMOS NETWOR LMOS
5.70%
INSTEEL IND IIIN
5.28%

Armstrong World Down to Strong Sell

by Zacks Equity Research

March 07, 2013 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

On Mar 5, Zacks Investment Research downgraded Armstrong World Industries, Inc. (AWI - Snapshot Report) to a Zacks Rank #5 (Strong Sell).

Why the Downgrade?
Following the release of its fourth-quarter 2012 results on Feb 19, earnings estimates for this $3.13 billon company witnessed a sharp downward revision. In the last 30 days, The Zacks Consensus Estimate for 2013 decreased 14% to $2.44 per share while that for 2014 was down 12% to $3.05 per share.
Though Armstrong World’s fourth-quarter earnings per share of earnings increased 89% to 34 cents, beating the Zacks Consensus Estimate by a penny, sales declined 2% to $613 million. Unfavorable foreign exchange, lower volume particularly in Europe and unfavorable mix offset the benefits from higher price.
The Building Products segment was the lone segment to witness revenue growth of 1% as higher volumes in the North American commercial business managed to mitigate volume declines in Europe. However, the Resilient Flooring segment’s revenues dipped 3%, driven by lower volumes in Europe and in North America where continued weakness in commercial sectors tied to public spending and lower home center sales dragged down volumes. The Wood Flooring segments revenues declined 3% due to the sale of the Patriot distribution business
For 2013, the company expects sales to be in the $2.7 to $2.8 billion, up 3% to 7% from 2012. Adjusted EBITDA is expected to be in the $390 to $420 million range, down 3% to up 5% compared with 2012. Adjusted EPS is expected to lie in the band of $2.30 to $2.60, down 8% to up 4% compared with 2012. For the first quarter of 2013, sales are expected to be between $600 and $650 million and adjusted EBITDA to be in the range of $68 to $83 million.
Armstrong’s volumes are expected to remain affected as global markets continue to struggle, particularly Europe. Furthermore, the outlook for residential repair and remodel activity also remains weak as customers remain cautious regarding their spending.
Other Stocks to Consider
Among the other stocks in the same industry, Headwaters Inc. (HW - Snapshot Report), James Hardie Industries plc (JHX - Snapshot Report) and Masco Corp. (MAS - Analyst Report) hold a Zacks #2 Rank (Buy) and are favorable options for investors.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.